Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Antibodies
Chemical & Compound Analysis
Chemistry, Manufacturing & Controls
Protein Sciences
Discovery Chemistry
MedChemExpress
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Real-World Data (RWD)
Market Access
No items found.
Blog
Cell Line-Derived Xenografts: A Reliable Platform for Preclinical Cancer Drug Testing
March 9, 2026
Sponsored by:
Sponsor
Read blog
Disease Models
Pharmacology
Cell Culture & Characterization
Biomarkers
Crown Bioscience
Chemistry, Manufacturing & Controls
Chemical & Compound Analysis
Discovery Chemistry
Raw Materials
No items found.
Blog
Five Reasons Leading CNS Programs Rely on BrainXell for Custom iPSC Models
February 25, 2026
Sponsored by:
Sponsor
Read blog
Disease Models
BrainXell Inc.
Blog
From the Colony to the Roadmap: The FDA's New Stance on NAMs and Why it Matters
February 23, 2026
Read blog
Disease Models
Pharmacology
DMPK
Toxicology
No items found.
Chemistry, Manufacturing & Controls
Chemical & Compound Analysis
Discovery Chemistry
Raw Materials
No items found.
Chemistry, Manufacturing & Controls
Chemical & Compound Analysis
Discovery Chemistry
Raw Materials
No items found.
Chemistry, Manufacturing & Controls
Chemical & Compound Analysis
Discovery Chemistry
Raw Materials
No items found.
Chemistry, Manufacturing & Controls
Chemical & Compound Analysis
Discovery Chemistry
Raw Materials
No items found.
Chemistry, Manufacturing & Controls
No items found.
Blog
Evolving Frontiers in Immunohistochemistry: Applications and Transformations in Modern Biotechnology
January 15, 2026
Sponsored by:
Sponsor
Read blog
Bioimaging
Biomarkers
Protein Sciences
Antibodies
Applied Pathology Systems
.avif)
Protein Sciences
Shuimu Biosciences
Disease Models
Instrumentation & Products
Satish R. Raj
Nasia Sheikh
Finapres Medical Systems
No items found.
Chemical & Compound Analysis
Björn Heitmann
Barbara Czarniecki
Bruker Corporation
No items found.
Disease Models
Jonas Treebak
Alexander Bartelt
Sable Systems International Inc.
No items found.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Michael Broder
Jesse Ortendahl
PHAR
HealthEconomics.com
Disease Models
Sue Bodine
Aurora Scientific, Inc.
American Physiological Society
Alliance for Aging Research
Disease Models
Paul Marvar
Benjamin Turley
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Market Access
Medical Communications
Health Economics & Outcomes Research (HEOR)
Steven Fountain
Sonya Snedecor
Sajjad Raza
PRECISIONheor
OPEN Health
PRMA Consulting
Scientist.com
Market Access
Medical Communications
Sajjad Raza
Steven Fountain
Sonya Snedecor
OPEN Health
PRECISIONheor
PRMA Consulting
Scientist.com
Disease Models
Stefano Gaburro
Brun Ulfhake
Tecniplast S.p.A.
American Physiological Society
Alliance for Aging Research
Disease Models
Aileen King
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Cell Culture & Characterization
Pharmacology
Toxicology
Daniel Merriman
Femi Egbebi
Krzysztof Inglot
Thermo Fisher Scientific
No items found.
Pharmacology
Jonathan Nakashima
Grace Walton
Certis Oncology Solutions, Inc.
Hera BioLabs
Scientist.com
Disease Models
Rohan Jagirdar
Data Sciences International
Harvard Bioscience, Inc.
No items found.
Podcast
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
July 13, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Podcast
Integrated Evidence Delivery: Why HEOR belongs at the heart of the Modern CRO
February 23, 2026
Read podcast
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Podcast
tHEORetically Speaking: Rethinking Decentralization in Direct-to-Patient Studies
October 6, 2025
Read podcast
Health Economics & Outcomes Research (HEOR)
Clinical Trials
.avif)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.
Whitepaper
Insights from Spatial Biology in Drug Discovery at IRBM: The Impact of Cellular Ecosystems
July 28, 2026
Sponsored by:
Sponsor
Access now
Bioimaging
Biomarkers
DNA & RNA
Protein Sciences
Disease Models
IRBM
Whitepaper
Direct to Biology: An Approach to Streamline the DMTA Cycle in PROTAC Discovery
July 7, 2026
Sponsored by:
Sponsor
Access now
Protein Sciences
Pharmacology
In Vitro Assays
DMPK
Concept Life Sciences